The Invesco QQQ Trust was recently back in the headlines, but not for performance reasons. Meanwhile, two alternatives that might be worth considering are the Vanguard Mega Cap Growth ETF and the iShares Expanded Tech Sector ETF.
Eli Lilly and Company reported robust second-quarter 2025 results, wherein it beat estimates on both the top and bottom lines. However, shares of Eli Lilly stock tumbled 14%. Here are ETFs with exposure to Eli Lilly that may still be worth a look.
Stocks were higher for the week as investors overlooked tariff uncertainty, but the bulls may get tested by next week's data on inflation and retail sales
Barrick Gold Corporation (NYSE: GOLD), one of the world's largest gold mining companies, is scheduled to report its next earnings on Monday, August 11, 2025, for the second fiscal quarter of 2025 (Q2/25). This upcoming report is a significant event for investors and market analysts, as it will provide
Gold prices experienced a dramatic surge and subsequent pullback on August 8, 2025, as the precious metal first soared to an unprecedented high on fears of new U.S. import tariffs, only to retreat swiftly following a clarifying statement from the White House. This sudden volatility underscored the profound sensitivity
Washington, D.C, 8th August 2025, ZEX PR WIRE, In August 2025, Bitcoin prices remained above $116,000. Amidst dovish signals from the Federal Reserve and the continued inflow of ETF funds, sentiment among both institutional and retail investors rebounded. Although the upward trend has slowed, the market generally expects Bitcoin to challenge $125,000 this
New IDYN actively managed ETF by BlackRock provides exposure to international markets outside US and adjusts factor allocation based on market conditions.
Tech-saturated Nasdaq 100 ETFs hit record highs despite U.S. tariff hike. Leading the pack were Invesco's QQQ, QQQM and QQQE. Strong performance driven by confident investors and stable big-cap techs.
Shares of medical device company ICU Medical (NASDAQ:ICUI)
fell 10.5% in the morning session after the company reported second-quarter results where a significant earnings beat was overshadowed by a year-over-year revenue decline and concerning cash flow performance. The medical device company reported a GAAP profit of $1.43 per share, significantly reversing a loss from the prior year and handily beating analyst expectations. However, investors appeared to focus on the 8% year-over-year decline in revenue, which landed at $548.9 million, even though it slightly surpassed analyst forecasts. Furthermore, the company's free cash flow was a negative $8.49 million, a stark reversal from a positive $62.67 million in the same period last year, indicating pressure on its cash generation. Despite the company also issuing full-year profit guidance that was well ahead of Wall Street estimates, the revenue dip and negative cash flow seemingly weighed more heavily on investor sentiment.
Gold futures prices jumped, causing a premium of over $125 per ounce, due to new tariffs on Swiss gold imports to the US. Impact on ETFs remains uncertain.
Putting any sum of money toward an investment is a big decision. You're likely to be happy with your choice if you buy two of Vanguard's most popular funds.
Amidst heightened cryptocurrency market volatility, Ripplecoin Mining has launched a daily stable income solution specifically designed for XRP users, offering investors a new, low-risk, and highly efficient path to digital asset appreciation
Los Angeles, California, 8th August 2025, ZEX PR WIRE, After a period of significant volatility, the cryptocurrency market is entering a new
